{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T16:32:56Z","timestamp":1757608376069,"version":"3.44.0"},"reference-count":25,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Emerg Med J"],"accepted":{"date-parts":[[2020,9,10]]},"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Government opioid policies\u2014such as the North Carolina Strengthen Opioid Misuse Prevention (STOP) Act\u2014have aided in lowering the days\u2019 supply of opioid prescriptions. However, what effect do these laws have on codeine-containing antitussive syrup? We aimed to assess the effect of the North Carolina STOP Act on ED opioid prescriptions written for &gt;5 days for acute pain\/non-pain diagnoses and whether it had an effect on the prescribing of codeine-containing antitussive syrup.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A retrospective study of two emergency departments, with an average annual census of 70\u2009000 and 22\u2009000 patients, from January to August of 2017 and 2018. We applied logistic regression techniques to calculate the odds of an opioid prescription for &gt;5 days. Opioid medication categories were formed to determine relational proportions. Two-tailed z-tests were used to test the difference in proportions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Our study included 5366 verifiable opioid prescriptions. The percentage of an opioid prescription for &gt;5 days decreased by 3.3% (95% CI \u22121.8% to \u22124.7%, p&lt;0.05) after the North Carolina STOP Act (9.8% to 6.5%; 95% CI 5.5% to 7.5%, p&lt;0.05). There was no statistically significant change in the prescribing of codeine syrup for &gt;5 days pre-STOP and post- STOP Act, respectively (91.5% and 90.4%; difference=\u22121.1%, p=0.83).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The North Carolina STOP Act was associated with a reduction in the overall percentage of opioid prescriptions for &gt;5 days for acute pain\/non-pain diagnoses. However, there was no statistically significant effect on the prescribing of codeine-containing antitussive syrup.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/emermed-2019-209008","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T17:25:49Z","timestamp":1603301149000},"page":"889-894","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of a state law on opioid-prescribing behaviour and the void affecting codeine-containing antitussive syrup"],"prefix":"10.1136","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7172-903X","authenticated-orcid":false,"given":"Warren M.","family":"Perry","sequence":"first","affiliation":[{"name":"Emergency Medicine Department, Emory University, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7157-814X","authenticated-orcid":false,"given":"Chris B.","family":"Agala","sequence":"additional","affiliation":[{"name":"Anesthesiology Department, University of North Carolina, Chapel Hill, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika M.","family":"Agala","sequence":"additional","affiliation":[{"name":"Emergency Department, University of North Carolina, Chapel Hill, North Carolina, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,10,21]]},"reference":[{"doi-asserted-by":"publisher","key":"2025090221392289000_38.12.889.1","DOI":"10.1136\/bmj.d5142"},{"unstructured":"European Monitoring Centre for Drugs and Drug Addiction . United Kingdom: country drug report 2019, 2019. Available: https:\/\/www.emcdda.europa.eu\/countries\/drug-reports\/2019\/united-kingdom_en","key":"2025090221392289000_38.12.889.2"},{"doi-asserted-by":"publisher","key":"2025090221392289000_38.12.889.3","DOI":"10.1016\/j.annemergmed.2015.11.033"},{"doi-asserted-by":"publisher","key":"2025090221392289000_38.12.889.4","DOI":"10.1016\/j.annemergmed.2014.11.015"},{"doi-asserted-by":"publisher","key":"2025090221392289000_38.12.889.5","DOI":"10.1056\/NEJMsa1610524"},{"doi-asserted-by":"publisher","key":"2025090221392289000_38.12.889.6","DOI":"10.1053\/ajem.2002.32643"},{"doi-asserted-by":"publisher","key":"2025090221392289000_38.12.889.7","DOI":"10.1016\/j.annemergmed.2012.06.013"},{"unstructured":"Stader DE et al . Colorado ACEP 2017 opioid prescribing & treatment guidelines: Colorado chapter, American College of Emergency Physicians, 2017.","key":"2025090221392289000_38.12.889.8"},{"unstructured":"North Carolina General Assembly . The strengthen opioid misuse prevention (stop) act of 2017 (session law 2017-74\/H243). Raleigh, North Carolina: North Carolina General Assembly, 2017.","key":"2025090221392289000_38.12.889.9"},{"doi-asserted-by":"publisher","key":"2025090221392289000_38.12.889.10","DOI":"10.1016\/j.jemermed.2016.07.120"},{"doi-asserted-by":"publisher","key":"2025090221392289000_38.12.889.11","DOI":"10.1016\/j.jpain.2017.11.010"},{"doi-asserted-by":"publisher","key":"2025090221392289000_38.12.889.12","DOI":"10.1016\/j.annemergmed.2017.03.057"},{"unstructured":"International Narcotics Control Board . Narcotic drugs 2017 estimated world requirements for 2018, 2017. Available: https:\/\/www.incb.org\/documents\/Narcotic-Drugs\/Technical-Publications\/2017\/Narcotic_drugs_technical_publication_2017.pdf","key":"2025090221392289000_38.12.889.13"},{"unstructured":"International Narcotics Control Strategy Report . Bureau of international narcotics and law enforcement Affairs, 2019.","key":"2025090221392289000_38.12.889.14"},{"unstructured":"National Institute for Health and Care Excellent . Cough (acute): antimicrobial prescribing. England, United Kingdom: National Institute for Health and Care Excellent, 2019.","key":"2025090221392289000_38.12.889.15"},{"doi-asserted-by":"publisher","key":"2025090221392289000_38.12.889.16","DOI":"10.1111\/j.2042-7158.1997.tb06039.x"},{"doi-asserted-by":"publisher","key":"2025090221392289000_38.12.889.17","DOI":"10.1016\/j.annemergmed.2014.03.025"},{"unstructured":"Feiveson A . What is the delta method and how is it used to estimate the standard error of a transformed parameter? Explanation of the delta method: STATA. Available: https:\/\/www.stata.com\/support\/faqs\/statistics\/delta-method\/","key":"2025090221392289000_38.12.889.18"},{"unstructured":"STATA . Stata statistical software. release 12. College Station, TX: Stata Corporation, 2001.","key":"2025090221392289000_38.12.889.19"},{"doi-asserted-by":"publisher","key":"2025090221392289000_38.12.889.20","DOI":"10.1371\/journal.pone.0076499"},{"doi-asserted-by":"publisher","key":"2025090221392289000_38.12.889.21","DOI":"10.1111\/add.13450"},{"doi-asserted-by":"publisher","key":"2025090221392289000_38.12.889.22","DOI":"10.5811\/westjem.2012.2.6915"},{"doi-asserted-by":"publisher","key":"2025090221392289000_38.12.889.23","DOI":"10.1016\/j.addbeh.2017.08.005"},{"doi-asserted-by":"publisher","key":"2025090221392289000_38.12.889.24","DOI":"10.1097\/ACI.0b013e3280115145"},{"doi-asserted-by":"publisher","key":"2025090221392289000_38.12.889.25","DOI":"10.1136\/ewjm.173.4.283"}],"container-title":["Emergency Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/emermed-2019-209008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T04:39:40Z","timestamp":1756874380000},"score":1,"resource":{"primary":{"URL":"https:\/\/emj.bmj.com\/lookup\/doi\/10.1136\/emermed-2019-209008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,21]]},"references-count":25,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,11,24]]},"published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1136\/emermed-2019-209008"],"URL":"https:\/\/doi.org\/10.1136\/emermed-2019-209008","relation":{},"ISSN":["1472-0205","1472-0213"],"issn-type":[{"type":"print","value":"1472-0205"},{"type":"electronic","value":"1472-0213"}],"subject":[],"published":{"date-parts":[[2020,10,21]]}}}